TrialThe Journal of antimicrobial chemotherapy2018

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness.

Oliver A Cornely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.